Home > NRC Library > ADAMS Public Documents

06-28799-01 594704 Alexion Pharmaceuticals, Inc.

Accession Number: ML17132A173

Date Released: Thursday, June 29, 2017

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML17132A174 - Alexion Pharmaceuticals, Inc., Amendment Request Ltr. Dated May 4, 2017. (2 page(s), 5/4/2017)
• ML17136A216 - Alexion Pharmaceuticals, Inc., e-mail dated May 16, 2017, Subject: Request for Additional Information Concerning Application for a License Amendment, Control 594704, License No. 06-28799-01, Docket No. 03032976. (2 page(s), 5/16/2017)
• ML17172A094 - Alexion Pharmaceuticals, Inc.; License Amendment Letter, Mail Control No. 594704. (3 page(s), 6/14/2017)
• ML17172A095 - Alexion Pharmaceuticals, Inc.; License Amendment No. 20, Mail Control No. 594704. (3 page(s), 6/4/2017)